Comprehensive Proteomic Profiling of Triple-Negative Breast Cancer-Derived Small Extracellular Vesicles Unveiled PXDN and GGT5 as Novel Protein Markers Implicated in Oncogenic Signaling Networks
Journal of Proteome Research · 2025
DOI: 10.1021/acs.jproteome.5c00553 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Proteome Research, 2025. Verfasst von Abdullah Khraibah und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa K1N 6N5, Canada. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Extracellular Vesicles, Biomarkers, Tumor, Proteomics. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Natural Sciences and Engineering Research Council of Canada.
Abstract (Originalsprache)
Breast cancer (BC) is the most prevalent cancer and the second leading cause of cancer-related mortality among women. Early detection and treatment can significantly improve survival rates. The potential application of small extracellular vesicles (sEVs) as biomarkers for early BC diagnosis has gained increasing attention, primarily due to their promise as a minimally invasive detection method. However, the specific protein signatures of sEVs are still not well understood. This study compared the proteomes of MDA-MB-231 and MCF-10A cells with their respective sEVs and conducted cross-comparisons between the two cell types and their sEV populations. Bioinformatic analyses revealed that MDA-MB-231 cell-derived sEVs are enriched with proteins involved in cancer growth and proliferation pathways. The proteins from these pathways can offer a valuable resource for triple-negative BC (TNBC) biomarkers. In this study, three proteins were selected based on their unique presence in MDA-MB-231 cell-derived sEVs and their association with pathways related to BC: peroxidasin homolog (PXDN), glutathione hydrolase 5 proenzyme (GGT5), and plasminogen activator inhibitor 1 (SERPINE1). These proteins were validated using synthetic heavy-labeled peptides and mass spectrometry-based parallel reaction monitoring, as well as Western blot analysis. This study highlights the potential of sEV-based proteins as noninvasive biomarkers for early TNBC detection, laying the groundwork for future diagnostic studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa K1N 6N5, Canada.
- John L. Holmes Mass Spectrometry Facility, University of Ottawa, Ottawa K1N 6N5, Canada.
Förderung
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Khraibah, A., Kasyanchyk, P., Zaripov, E. A., Radchanka, A., Minic, Z., & Berezovski, M. V. (2025). Comprehensive Proteomic Profiling of Triple-Negative Breast Cancer-Derived Small Extracellular Vesicles Unveiled PXDN and GGT5 as Novel Protein Markers Implicated in Oncogenic Signaling Networks. Journal of Proteome Research. https://doi.org/10.1021/acs.jproteome.5c00553
Vancouver
Khraibah A, Kasyanchyk P, Zaripov EA, Radchanka A, Minic Z, Berezovski MV. Comprehensive Proteomic Profiling of Triple-Negative Breast Cancer-Derived Small Extracellular Vesicles Unveiled PXDN and GGT5 as Novel Protein Markers Implicated in Oncogenic Signaling Networks. Journal of Proteome Research. 2025. doi:10.1021/acs.jproteome.5c00553
BibTeX
@article{Khraibah2025,
author = {Khraibah, Abdullah and Kasyanchyk, Petr and Zaripov, Emil A and Radchanka, Aliaksandra and Minic, Zoran and Berezovski, Maxim V},
title = {Comprehensive Proteomic Profiling of Triple-Negative Breast Cancer-Derived Small Extracellular Vesicles Unveiled PXDN and GGT5 as Novel Protein Markers Implicated in Oncogenic Signaling Networks},
journal = {Journal of Proteome Research},
year = {2025},
doi = {10.1021/acs.jproteome.5c00553}
}
EUVIMED